Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 10

1.

Abnormal expression of calcyphosine is associated with poor prognosis and cell biology function in colorectal cancer.

Shao W, Wang Q, Wang F, Jiang Y, Xu M, Xu J.

Onco Targets Ther. 2016 Jan 25;9:477-87. doi: 10.2147/OTT.S92226. eCollection 2016.

2.

Gene expression identifies heterogeneity of metastatic behavior among gastrointestinal stromal tumors.

Skubitz KM, Geschwind K, Xu WW, Koopmeiners JS, Skubitz AP.

J Transl Med. 2016 Feb 13;14:51. doi: 10.1186/s12967-016-0802-3.

3.

Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer.

Johansson HJ, Sanchez BC, Forshed J, Stål O, Fohlin H, Lewensohn R, Hall P, Bergh J, Lehtiö J, Linderholm BK.

Clin Proteomics. 2015 Mar 21;12(1):8. doi: 10.1186/s12014-015-9080-y. eCollection 2015.

4.

Genome-wide modulation of gene transcription in ovarian carcinoma cells by a new mithramycin analogue.

Vizcaíno C, Núñez LE, Morís F, Portugal J.

PLoS One. 2014 Aug 11;9(8):e104687. doi: 10.1371/journal.pone.0104687. eCollection 2014.

5.

Gene expression identifies heterogeneity of metastatic behavior among high-grade non-translocation associated soft tissue sarcomas.

Skubitz KM, Skubitz AP, Xu WW, Luo X, Lagarde P, Coindre JM, Chibon F.

J Transl Med. 2014 Jun 20;12:176. doi: 10.1186/1479-5876-12-176.

6.

Discovery analysis of TCGA data reveals association between germline genotype and survival in ovarian cancer patients.

Braun R, Finney R, Yan C, Chen QR, Hu Y, Edmonson M, Meerzaman D, Buetow K.

PLoS One. 2013;8(3):e55037. doi: 10.1371/journal.pone.0055037. Epub 2013 Mar 21.

7.

Mechanistic modeling of the effects of myoferlin on tumor cell invasion.

Eisenberg MC, Kim Y, Li R, Ackerman WE, Kniss DA, Friedman A.

Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20078-83. doi: 10.1073/pnas.1116327108. Epub 2011 Nov 30.

8.

Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients.

Andersen JD, Boylan KL, Jemmerson R, Geller MA, Misemer B, Harrington KM, Weivoda S, Witthuhn BA, Argenta P, Vogel RI, Skubitz AP.

J Ovarian Res. 2010 Sep 10;3:21. doi: 10.1186/1757-2215-3-21.

9.

S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival.

DeRycke MS, Andersen JD, Harrington KM, Pambuccian SE, Kalloger SE, Boylan KL, Argenta PA, Skubitz AP.

Am J Clin Pathol. 2009 Dec;132(6):846-56. doi: 10.1309/AJCPTK87EMMIKPFS.

10.

Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors.

Skubitz KM, Pambuccian S, Manivel JC, Skubitz AP.

J Transl Med. 2008 May 6;6:23. doi: 10.1186/1479-5876-6-23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk